Document is current
Any future updates will be listed below
-
Authors
Ryan, Donna H. https://orcid.org/0000-0001-8374-2277
- License Information
-
More Information
Article History
Accepted: 22 April 2025
First Online: 5 May 2025
Declarations
:
: D.H.R has received personal remuneration from services as a scientific advisor to Abbvie, Altimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Biohaven, Calibrate, Carmot/Roche, CINRx, Currax, Epitomee, Fractyl, Gila, Lilly, Nestle, Novo Nordisk, Pfizer, Regeneron, Scientific Intake, Source Bio, Structure Therapeutics, Wondr Health, and Zealand, She serves on Speaker’s Bureau for Novo Nordisk and Lilly. She accepted stock options from Epitomee, Calibrate, Roman, Scientific Intake, and Xeno Bioscience. She is remunerated for Data Monitoring Committee service from IQVIA (Rhythm), Lilly and CinRx.
